Table 1.
Peak nasal inspiratory flow (PNIF) – comparison between active and placebo.
| PNIF | Product | N | Mean (L/min) | SD (L/min) | SEM (L/min) |
|---|---|---|---|---|---|
| Preallergen exposure | Active | 43 | 135.93 | 44.189 | 6.739 |
| Placebo | 43 | 134.26 | 38.523 | 5.875 | |
| Time 0 | Active | 43 | 120.74 | 38.275 | 5.837 |
| Placebo | 43 | 117.13 | 36.237 | 5.526 | |
| Time 15 | Active | 43 | 116.16 | 36.311 | 5.537 |
| Placebo | 43 | 110.16 | 36.592 | 5.580 | |
| Time 30 | Active | 43 | 118.57 | 41.440 | 6.320 |
| Placebo | 43 | 114.65 | 41.913 | 6.392 | |
| Time 60 | Active | 43 | 119.19 | 36.040 | 5.496 |
| Placebo | 43 | 116.40 | 42.559 | 6.490 | |
| Time 90 | Active | 43 | 123.95 | 36.308 | 5.537 |
| Placebo | 43 | 122.64 | 42.883 | 6.540 | |
| Time 120 | Active | 42 | 127.86 | 40.100 | 6.188 |
| Placebo | 42 | 126.90 | 41.17 | 6.355 |
N represents the number of subjects having complete pairs for the time points in comparison. Time is expressed in minutes postallergen exposure.